Pre-market top loser: Clearbridge Health (1H3.SI) down 33.33% 27 Jan 2026: monitor liquidity
Clearbridge Health Limited (1H3.SI stock) dropped 33.33% pre-market to S$0.002 on 27 Jan 2026, making it one of the SES top losers. Trading volume hit 36,278,000 shares, well above the 50-day average, signalling active selling. The move follows thin market capitalisation dynamics and limited liquidity, and it sharpens focus on valuation and near-term cash flow risks for investors.
1H3.SI stock: pre-market price action and volume
Clearbridge Health (1H3.SI stock) opened at S$0.002 on 27 Jan 2026, down S$0.001 or 33.33% from the previous close of S$0.003. Intraday range shows a low of S$0.002 and high of S$0.003. Volume surged to 36,278,000 versus an average of 8,622,676, indicating outsized selling interest in a small-cap name with market cap S$8,591,642.
1H3.SI stock: drivers, news and upcoming catalysts
There is no single major corporate announcement linked to the drop; trading appears driven by liquidity and short-term flows. Clearbridge’s next earnings announcement is scheduled for 27 Feb 2026, which could be the next catalyst. For peer and competitive context see the Investing.com comparison page for Clearbridge and similar healthcare stocks source.
1H3.SI stock: valuation and fundamentals
On fundamentals, 1H3.SI stock shows mixed metrics: price to sales is 1.16, price to book is 0.27, and PE is not meaningful due to negative earnings. Revenue per share is 0.00453 and net income per share is -0.00130. The company posts a current ratio of 1.73 and debt to equity of 0.12, highlighting modest leverage but persistent negative profitability.
1H3.SI stock: technicals and liquidity risks
Technicals show an RSI of 51.74 and ADX of 66.13, suggesting a strong trend on thin data. On‑balance volume is deeply negative and average daily liquidity is low relative to big-cap peers, raising execution risk for large orders. Meyka AI rates 1H3.SI with a score out of 100: 57.37 (C+) — HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. These grades are informational and not financial advice.
1H3.SI stock: price targets, forecast and scenarios
Meyka AI’s forecast model projects a 12‑month price around S$0.00933. Against the current price of S$0.002, that implies an upside of 366.61%. Short-term traders may use a nearer target of S$0.003, while a downside test to the year low of S$0.001 would imply -50.00% from today. Forecasts are model-based projections and not guarantees. Risk factors include continued low liquidity, negative margins, and weak cash flow.
Final Thoughts
Clearbridge Health (1H3.SI stock) is a pre-market top loser after a sharp 33.33% decline to S$0.002 on 27 Jan 2026. The move highlights liquidity fragility in small-cap healthcare names on the SES and raises execution risk for larger trades. Fundamentals show a low price‑to‑book of 0.27 and negative net income per share of -0.00130, which underline ongoing profitability pressure. Technicals signal a strong directional trend but are distorted by thin volume. Meyka AI’s forecast model projects S$0.00933 in 12 months, implying +366.61% upside versus today, but also leaves room for downside to S$0.001. Investors should weigh the C+ grade from Meyka AI and the company’s upcoming 27 Feb 2026 earnings release before adjusting positions. This is data-driven market analysis from an AI‑powered market analysis platform and not investment advice; use stop levels and position sizing to manage risk.
FAQs
Why did 1H3.SI stock fall pre-market?
The pre-market drop in 1H3.SI stock appears driven by thin liquidity and heavy selling. No major corporate news matched the move. Elevated volume and a small market cap amplified price swings ahead of earnings on 27 Feb 2026.
What are the valuation metrics for 1H3.SI stock?
1H3.SI stock trades at price to sales 1.16 and price to book 0.27. PE is not meaningful due to negative earnings. Key concerns are negative net income per share and weak operating cash flow.
What forecast and targets exist for 1H3.SI stock?
Meyka AI’s forecast projects S$0.00933 in 12 months for 1H3.SI stock, implying about +366.61% upside from S$0.002. Short‑term target is S$0.003. Forecasts are model projections and not guarantees.
How does liquidity affect trading 1H3.SI stock?
Low market cap and thin order books mean 1H3.SI stock can move sharply on modest trades. Average volume is 8,622,676, but spikes like 36,278,000 increase volatility and widen spreads, raising execution risk.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
